--- title: "HealthTab™ Enters Multi-Year Collaboration Agreement with Abbott for Point-of-Care Testing Across the UK" type: "News" locale: "en" url: "https://longbridge.com/en/news/296477430.md" description: "In Vancouver, British Columbia on August 20, 2026, AVRICORE HEALTH INC. (TSXV: AVCR) shared news of their subsidiary HealthTab Ltd collaborating with Abbott. The agreement aims to provide Abbott's point-of-care testing products via the HealthTab™ platform in the UK. This partnership will enhance access to Abbott's healthcare solutions and further expand HealthTab's offerings, benefiting users in the UK." datetime: "2026-08-20T10:32:04.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/296477430.md) - [en](https://longbridge.com/en/news/296477430.md) - [zh-HK](https://longbridge.com/zh-HK/news/296477430.md) generator: "portal-rs" --- # HealthTab™ Enters Multi-Year Collaboration Agreement with Abbott for Point-of-Care Testing Across the UK In Vancouver, British Columbia on August 20, 2026, AVRICORE HEALTH INC. (TSXV: AVCR) shared news of their subsidiary HealthTab Ltd collaborating with Abbott. The agreement aims to provide Abbott's point-of-care testing products via the HealthTab™ platform in the UK. This partnership will enhance access to Abbott's healthcare solutions and further expand HealthTab's offerings, benefiting users in the UK. ### Related Stocks - [ABT.US](https://longbridge.com/en/quote/ABT.US.md) ## Related News & Research - [Avricore Health’s HealthTab signs multi-year collaboration with Abbott for UK point-of-care testing distribution](https://longbridge.com/en/news/296474749.md) - [Xcel Wealth Management LLC Cuts Stock Holdings in Abbott Laboratories $ABT](https://longbridge.com/en/news/296700328.md) - [Murphy Pohlad Asset Management LLC Purchases 12,140 Shares of Abbott Laboratories $ABT](https://longbridge.com/en/news/296461096.md) - [Did Abbott’s Q2 Beat and Profit Hike Just Shift Abbott Laboratories’ (ABT) Investment Narrative?](https://longbridge.com/en/news/296546525.md) - [Jefferies Sticks to Their Buy Rating for Abbott Laboratories (ABT)](https://longbridge.com/en/news/296645903.md) --- > **Disclaimer: This article is for reference only and does not constitute any investment advice.**